Published in
Springer, Cancer Immunology, Immunotherapy, 1(69), p. 57-67, 2019
DOI: 10.1007/s00262-019-02438-1
Links
Tools
A highly efficient modality to block the degradation of tryptophan for cancer immunotherapy: locked nucleic acid-modified antisense oligonucleotides to inhibit human indoleamine 2,3-dioxygenase 1/tryptophan 2,3-dioxygenase expression
Journal article published in 2019 by
Richard Klar 
,
Sven Michel,
Monika Schell,
Lisa Hinterwimmer,
Alfred Zippelius ,
Frank Jaschinski
,
Sven Michel,
Monika Schell,
Lisa Hinterwimmer,
Alfred Zippelius ,
Frank Jaschinski
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 